News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
620,716 Results
Type
Article (49214)
Company Profile (157)
Press Release (571345)
Section
Business (180320)
Career Advice (1976)
Deals (29607)
Drug Delivery (107)
Drug Development (81295)
Employer Resources (121)
FDA (16727)
Job Trends (12818)
News (316457)
Policy (33044)
Tag
Academia (2445)
Alliances (47730)
Alzheimer's disease (1326)
Antibody-drug conjugate (ADC) (109)
Approvals (16665)
Artificial intelligence (170)
Bankruptcy (256)
Best Places to Work (9964)
Biotechnology (112)
Breast cancer (200)
Cancer (1505)
Cardiovascular disease (122)
Career advice (1672)
Cell therapy (311)
Clinical research (65197)
Collaboration (568)
Compensation (204)
COVID-19 (2464)
C-suite (122)
Data (1446)
Diabetes (194)
Diagnostics (5241)
Earnings (70438)
Employer resources (109)
Events (92947)
Executive appointments (438)
FDA (17498)
Funding (479)
Gene therapy (212)
GLP-1 (694)
Government (4244)
Healthcare (16083)
Infectious disease (2550)
Inflammatory bowel disease (119)
Interviews (361)
IPO (13226)
Job creations (3265)
Job search strategy (1416)
Layoffs (430)
Legal (7549)
Lung cancer (224)
Manufacturing (215)
Medical device (10768)
Medtech (10773)
Mergers & acquisitions (16644)
Metabolic disorders (534)
Neuroscience (1699)
NextGen: Class of 2025 (5464)
Non-profit (3887)
Northern California (1677)
Obesity (306)
Opinion (240)
Patents (125)
People (51291)
Phase I (19862)
Phase II (28209)
Phase III (21928)
Pipeline (604)
Postmarket research (3131)
Preclinical (8527)
Radiopharmaceuticals (239)
Rare diseases (286)
Real estate (4869)
Regulatory (22859)
Research institute (2261)
Resumes & cover letters (303)
Southern California (1470)
Startups (3212)
United States (14931)
Vaccines (557)
Weight loss (238)
Date
Today (92)
Last 7 days (803)
Last 30 days (2067)
Last 365 days (32705)
2025 (1378)
2024 (32895)
2023 (36577)
2022 (47125)
2021 (50262)
2020 (48082)
2019 (41025)
2018 (31068)
2017 (30363)
2016 (29510)
2015 (33906)
2014 (27838)
2013 (23896)
2012 (25069)
2011 (25505)
2010 (24302)
Location
Africa (822)
Arizona (127)
Asia (41583)
Australia (6617)
California (3775)
Canada (1379)
China (367)
Colorado (168)
Connecticut (194)
Europe (86557)
Florida (550)
Georgia (127)
Illinois (373)
Indiana (216)
Maryland (651)
Massachusetts (2958)
Michigan (148)
Minnesota (239)
New Jersey (1128)
New York (1113)
North Carolina (743)
Northern California (1677)
Ohio (136)
Pennsylvania (843)
South America (1094)
Southern California (1470)
Texas (548)
Utah (109)
Washington State (411)
620,716 Results for "hunan tigermed xiangya drug r and d ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit
NeuroSense Therapeutics Ltd., a company developing novel treatments for severe neurodegenerative diseases, announces that Vice President of R&D, Dr. Shiran Zimri will be a key presenter at the ALS Drug Development Summit in Boston, Mass.
May 20, 2024
·
7 min read
Business
Tigermed Reports Full Year 2023 Results
Hangzhou Tigermed Consulting Co., Ltd., a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023.
March 28, 2024
·
9 min read
Press Releases
Tigermed Reports 2024 Interim Results
August 28, 2024
·
9 min read
Career Advice
Computational Biology, Data Science Hot Areas for Oncology R&D Hiring
As market values increase for computational biology and data science, biopharma companies are looking to hire R&D professionals in those areas. A biotech talent acquisition expert shares his insights on these in-demand roles.
January 2, 2025
·
5 min read
·
Angela Gabriel
Drug pricing
Part D Drugs Almost Doubled in Cost Since Launch, Underscoring Importance of IRA: AARP
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into small-molecule drug development.
January 10, 2025
·
3 min read
·
Tristan Manalac
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
Samsung Bioepis Co., Ltd. issued its 2024 sustainability report, underscoring its progress toward building more sustainable and socially responsible practices in access to medicines, R&D innovation, and product quality and patient safety.
June 25, 2024
·
5 min read
Business
Tigermed Reports 2023 Interim Results
Hangzhou Tigermed Consulting Co., Ltd., a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its interim results for the first half of 2023, ended June 30, 2023.
August 25, 2023
·
9 min read
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
Nxera Pharma Co. Ltd, announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neurological diseases, resulting in a payment of US$10 million to Nxera.
June 26, 2024
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
December 12, 2024
·
5 min read
Drug Development
Facing ‘Daunting’ Launch Schedule, Moderna to Slash $4B in R&D Spend by 2028
Analysts expressed skepticism about plans detailed by Moderna’s R&D chief Stephen Hoge to trim research spending in preparation for the launch of up to 10 new products.
September 13, 2024
·
4 min read
·
Annalee Armstrong
1 of 62,072
Next
